Number of people requiring post-exposure prophylaxis to end leprosy: A modeling study
- PMID: 33630836
- PMCID: PMC7906365
- DOI: 10.1371/journal.pntd.0009146
Number of people requiring post-exposure prophylaxis to end leprosy: A modeling study
Abstract
Background: Worldwide, around 210,000 new cases of leprosy are detected annually. To end leprosy, i.e. zero new leprosy cases, preventive interventions such as contact tracing and post-exposure prophylaxis (PEP) are required. This study aims to estimate the number of people requiring PEP to reduce leprosy new case detection (NCD) at national and global level by 50% and 90%.
Methodology/principal findings: The individual-based model SIMCOLEP was fitted to seven leprosy settings defined by NCD and MB proportion. Using data of all 110 countries with known leprosy patients in 2016, we assigned each country to one of these settings. We predicted the impact of administering PEP to about 25 contacts of leprosy patients on the annual NCD for 25 years and estimated the number of contacts requiring PEP per country for each year. The NCD trends show an increase in NCD in the first year (i.e. backlog cases) followed by a significant decrease thereafter. A reduction of 50% and 90% of new cases would be achieved in most countries in 5 and 22 years if 20.6 and 40.2 million people are treated with PEP over that period, respectively. For India, Brazil, and Indonesia together, a total of 32.9 million people requiring PEP to achieve a 90% reduction in 22 years.
Conclusion/significance: The leprosy problem is far greater than the 210,000 new cases reported annually. Our model estimates of the number of people requiring PEP to achieve significant reduction of new leprosy cases can be used by policymakers and program managers to develop long-term strategies to end leprosy.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures

Similar articles
-
Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts.BMC Infect Dis. 2019 Dec 5;19(1):1033. doi: 10.1186/s12879-019-4649-0. BMC Infect Dis. 2019. PMID: 31805862 Free PMC article.
-
Role of contact tracing and prevention strategies in the interruption of leprosy transmission.Lepr Rev. 2014 Mar;85(1):2-17. Lepr Rev. 2014. PMID: 24974438
-
Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin.BMJ Open. 2016 Nov 17;6(11):e013633. doi: 10.1136/bmjopen-2016-013633. BMJ Open. 2016. PMID: 27856484 Free PMC article.
-
The long-term impact of the Leprosy Post-Exposure Prophylaxis (LPEP) program on leprosy incidence: A modelling study.PLoS Negl Trop Dis. 2021 Mar 31;15(3):e0009279. doi: 10.1371/journal.pntd.0009279. eCollection 2021 Mar. PLoS Negl Trop Dis. 2021. PMID: 33788863 Free PMC article.
-
Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme.Lancet Glob Health. 2021 Jan;9(1):e81-e90. doi: 10.1016/S2214-109X(20)30396-X. Epub 2020 Oct 29. Lancet Glob Health. 2021. PMID: 33129378 Review.
Cited by
-
Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts.BMC Infect Dis. 2023 May 9;23(1):310. doi: 10.1186/s12879-023-08290-0. BMC Infect Dis. 2023. PMID: 37161571 Free PMC article. Clinical Trial.
-
Less is more: Developing an approach for assessing clustering at the lower administrative boundaries that increases the yield of active screening for leprosy in Bihar, India.PLoS Negl Trop Dis. 2022 Sep 12;16(9):e0010764. doi: 10.1371/journal.pntd.0010764. eCollection 2022 Sep. PLoS Negl Trop Dis. 2022. PMID: 36095018 Free PMC article.
-
Modulation of the Response to Mycobacterium leprae and Pathogenesis of Leprosy.Front Microbiol. 2022 Jun 2;13:918009. doi: 10.3389/fmicb.2022.918009. eCollection 2022. Front Microbiol. 2022. PMID: 35722339 Free PMC article. Review.
-
The Epidemiological Impact of Community-Based Skin Camps on Leprosy Control in East Hararghe Zone, Ethiopia: a Modelling Study.J Epidemiol Glob Health. 2025 Mar 4;15(1):34. doi: 10.1007/s44197-025-00370-5. J Epidemiol Glob Health. 2025. PMID: 40035901 Free PMC article.
-
A Review of the Efficacy, Safety, and Feasibility of Rifamycin-Based Post-Exposure Chemoprophylaxis for Leprosy.Trop Med Infect Dis. 2025 Mar 21;10(4):84. doi: 10.3390/tropicalmed10040084. Trop Med Infect Dis. 2025. PMID: 40278757 Free PMC article. Review.
References
-
- World Health Organization. Guidelines for the Diagnosis, Treatment and Prevention of Leprosy. 1st ed. Geneva: WHO; 2018. 106 p.
-
- Bratschi MW, Steinmann P, Wickenden A, Gillis TP. Current knowledge on Mycobacterium leprae transmission: a systematic literature review. Lepr Rev. 2015;86:142–55. - PubMed
-
- Global leprosy update, 2018: moving towards a leprosy free world. Wkly Epidemiol Rec. 2019; 94(35/36):389–412.
-
- World Health Organization. Leprosy—Global target attained. Wkly Epidemiol Rec. 2001;76(20):149–56. Available from: http://www.who.int/docstore/wer/pdf/2001/wer7620.pdf - PubMed
-
- Global leprosy situation, 2006. Wkly Epidemiol Rec. 2006;81(32):309–16. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous